key: cord-0748082-182dncb7
authors: Vafea, M. T.; Atalla, E.; Kalligeros, M.; Mylona, E. K.; Shehadeh, F.; Mylonakis, E.
title: Chest CT findings in asymptomatic cases with COVID-19: a systematic review and meta-analysis
date: 2020-08-12
journal: Clin Radiol
DOI: 10.1016/j.crad.2020.07.025
sha: 3900f078b2d05a86ea280b6b7fc1f980a0775b0f
doc_id: 748082
cord_uid: 182dncb7

Abstract Aim To determine the overall rate of chest imaging findings in asymptomatic cases, describe the most common patterns found, and determine the rate of later symptom development in these initially asymptomatic cases. Materials and methods The PubMed and EMBASE databases were searched until 1 May 2020, for studies examining the proportion of positive chest imaging findings in asymptomatic cases diagnosed with COVID-19 and a random-effects meta-analysis of proportions was performed. Heterogeneity was assessed using the I2 statistic. Results Among 858 non-duplicate studies, seven studies with a total of 231 asymptomatic cases met the inclusion criteria. In the primary analysis, the pooled estimate of the overall rate of positive chest computed tomography (CT) findings among asymptomatic cases was 63% (95% confidence interval [CI]: 44–78%). Among 155/231 cases that were followed up for later symptom development, 90/155 remained asymptomatic and 65/155 developed symptoms during the study period (that ranged between seven and 30 days of follow-up). The pooled estimate of the rate of positive chest CT findings was 62% (95% CI: 38–81%) in cases that remained asymptomatic, while it was 90% (95% CI: 49–99%) in cases that developed symptoms. Among CT findings, the pooled estimate of the overall rate of ground-glass opacities (GGO) at CT alone was 71% (95% CI: 50–86%). Among other CT findings reported, 22/231 patients had GGO with consolidation, 7/231 patients had stripe shadows with or without GGO, and 8/231 patients had GGO with interlobular septal thickening. Among initially asymptomatic cases with positive CT findings, the pooled estimate of the overall rate of later symptom development was 26% (95% CI: 14–43%). Conclusion In COVID-19, asymptomatic cases can have positive chest CT findings, and COVID-19 should be considered among cases with CT abnormalities even when there are no other symptoms. There is a need for close clinical monitoring of asymptomatic cases with radiographic findings as a significant percentage will develop symptoms.

RESULTS: Among 858 non-duplicate studies, seven studies with a total of 231 asymptomatic cases met the inclusion criteria. In the primary analysis, the pooled estimate of the overall rate of positive chest computed tomography (CT) findings among asymptomatic cases was 63% (95% confidence interval [CI] : 44-78%). Among 155/231 cases that were followed up for later symptom development, 90/155 remained asymptomatic and 65/155 developed symptoms during the study period (that ranged between seven and 30 days of follow-up). The pooled estimate of the rate of positive chest CT findings was 62% (95% CI: 38-81%) in cases that remained asymptomatic, while it was 90% (95% CI: 49-99%) in cases that developed symptoms. Among CT findings, the pooled estimate of the overall rate of ground-glass opacities (GGO) at CT alone was 71% (95% CI: 50-86%). Among other CT findings Patients with COVID-19 present with fever, dry cough, fatigue, sputum production, shortness of breath, sore throat, headache, nausea, vomiting, and diarrhoea 4 ; however, asymptomatic infected individuals are of great concern as they undermine control interventions that rely on identifying symptomatic cases to contain the pandemic 5 and >40% of cases are infected by an asymptomatic or pre-symptomatic carrier 6 . Notably, chest imaging findings are very common in COVID-19 7, 8 . Most commonly, patients present with bilateral or multilobar involvement and with ground-glass opacities (GGO) 8 . The purpose of this systematic review and meta-analysis is to determine the overall rate of chest imaging findings in asymptomatic cases, describe the most common patterns found and determine the rate of later symptom development in these initially asymptomatic cases.

This review followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines 9 . The PRISMA checklist for this review is provided in Electronic Supplementary Material Table S1 .

The Pubmed and EMBASE databases were searched until 1 May 2020, for articles reporting chest imaging findings in asymptomatic cases with COVID-19. The following combination of keywords was used for search (all fields):

(covid OR sars-cov2 OR 2019-ncov) AND (imaging OR "computed tomography" OR CT OR Xray OR asymptomatic). Disagreements and inconsistencies were resolved by a third author (M.K.).

The following information were extracted from each eligible study: number of asymptomatic cases, number of asymptomatic cases with chest imaging findings, type of imaging findings, and potential development of symptoms among asymptomatic cases.

Based on the available data in the studies, cases were further divided into two groups (remained asymptomatic and developed symptoms), based on the development of clinical symptoms. The "remained asymptomatic" group included cases that did not have clinical symptoms of infection when tested positive for SARS-CoV-2 and never developed symptoms during the study period. Therefore, this group included individuals with subclinical infection 5 .

The "developed symptoms" group included cases that did not have clinical symptoms of infection when tested positive for SARS-CoV-2, but developed symptoms later on during the study period. Therefore, these were individuals that when tested for SARS-CoV-2 were in the incubation period 5 .

In the primary analysis, a random effects meta-analysis of proportions was performed using the DerSimonian-Laird model 10 and the logit transformation to determine the overall positive chest imaging findings rate (pooled estimate) J o u r n a l P r e -p r o o f among asymptomatic cases with COVID-19. A random effects model was selected, because it was assumed that the rates are heterogeneous due to differences in the study settings as well as differences in the study populations, in terms of age, comorbidities, etc.

In the secondary analysis, only studies reporting later symptom development with associated chest imaging findings for each case were included.

Subgroup analysis was performed, including cases that remained symptomatic and cases that developed symptoms. Common between variance was assumed, to determine the proportion of the heterogeneity that could be explained by the subgroups.

In the tertiary analysis, only initially asymptomatic patients with positive CT were included. Among them, a meta-analysis of proportions was performed to calculate the rate of GGO alone in their CT. Furthermore, in the tertiary analysis, a meta-analysis of proportions was performed to calculate the rate of symptom development among them. Meta-analyses of proportions and subgroup analysis were performed, and forest plots using R statistics software were created 11 . R statistics software was also applied to assess heterogeneity between the studies included in the meta-analyses (Cochran Q test) 12 and to determine the inconsistency across the studies included (I 2 statistic) 13 . The criterion for statistical significance for the test for heterogeneity was set at alpha =0.05.

Although this is a meta-analysis of proportions and the risk of publication bias is limited 14 , the latter were included in the analysis to be comprehensive. The risk of publication bias was assessed and visualised using a funnel plot 15 . 

All seven studies that were included in the meta-analysis described chest CT findings in cases that had no clinical manifestations of viral infection at the time they were tested positive for SARS-CoV-2. In total, 231 asymptomatic cases were included in the seven studies. Table 1 summarises in detail the characteristics of each study 5,16-21 . As noted above, only one study reported chest radiograph findings, so chest radiograph findings were not included in the analysis.

Regarding symptom development, after the diagnosis and isolation of the asymptomatic cases, six studies reported the clinical course of included cases 5, [16] [17] [18] 20, 21 . When reported, the follow-up in the studies ranged from 7-30 days. Among the cases included in these studies, 90 cases remained asymptomatic during the study period, whereas 65 cases developed symptoms at some point during the study period. Notably in three studies, imaging findings were not linked to specific cases, so they were not included in the secondary analysis 16,20,21 . J o u r n a l P r e -p r o o f 8 CT findings are described in detail in Table 1 . The most common CT finding in all subgroup categories was GGO and was present alone (in 67/231 patients) or together with other findings including consolidation shadow (22/231 patients), stripe shadows (7/231 patients) and interlobular septal thickening (8/231 patients) 5, [16] [17] [18] [19] 21 . The findings were most commonly peripheral and were bilateral or unilateral (mostly involving a single lobe) 16, 17, 19, 21 .

Studies included in all of the proportional meta-analyses and the metaanalysis of odds ratios were heterogeneous, as determined by the Cochrane Q test and I 2 statistic. Using the random-effects model, the pooled estimate of the overall rate of initially asymptomatic cases with positive chest CT findings was 63% (95% CI: 44-78%) and the heterogeneity was substantial (I 2 80%, p<0.01). In addition, a forest plot was constructed to visualise the pooled estimates with their confidence intervals (Fig. 2) and a funnel plot for the assessment of publication bias (Fig. 3) ; however, no statistical test to assess this bias was conducted, as <10 studies were included in the analysis and, in this case, the power of the tests was too low to distinguish chance from real asymmetry 22 .

In the secondary analysis, only studies that reported later symptom development with associated chest imaging findings for each case were included. A subgroup analysis was performed and the cases were divided into those who remained asymptomatic and those who developed symptoms.

Using the random-effects model, among the cases that remained asymptomatic the pooled estimate of the rate positive chest CT findings was J o u r n a l P r e -p r o o f 62% (95% CI: 38-81%). Among the individuals who developed symptoms, the pooled estimate of the rate of positive chest CT findings was 90% (95% CI: 47-84%). The pooled estimate of the overall rate of initially asymptomatic cases included in the secondary analysis with positive chest CT findings was 68% (95% CI: 47-84%). A forest plot was constructed (Fig. 4) .

In the tertiary analysis, initially asymptomatic cases with normal CT were excluded and only initially asymptomatic cases with positive chest CT findings were included. Using the random-effects model among these cases, the pooled estimate of the overall rate of GGO alone in the CT was 71% (95% CI: 50-86%). A forest plot was constructed (Fig. 5) . For each study, the "cases" column presents the number of asymptomatic cases with GGO in their CT and the "total" column presents the number of initially asymptomatic cases with positive chest CT findings in the study. Among the cases included in the tertiary analysis, the pooled estimate of the overall rate of symptom development was 26% (95% CI: 14-43%). A forest plot was constructed (Fig.   6 ) and the "cases" column presents the number of cases that developed symptoms and the "total" column presents the number of initially asymptomatic cases with positive chest CT findings. In both the forest plots in Figs. 5 and 6, the "proportion" column presents the proportion for each study with their 95% CI and in bold are presented the pooled estimates of the overall rates with their 95% CI.

Asymptomatic cases with COVID-19 are of great concern. They contribute to the spread of SARS-CoV-2 23 , with similar transmission rates as symptomatic Interestingly, the present study found that the rate of symptom development in initially asymptomatic cases with chest CT findings is substantial. This should raise concern among clinicians towards close monitoring of patients that test Finally, asymptomatic individuals with positive chest CT findings should be followed closely, as a significant proportion will eventually develop symptoms.

Pan F, Ye T, Sun P, Gui S, Liang B, Li L. 

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

COVID-19: what is next for public health ?

Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

Clinical characteristics of coronavirus disease 2019 in China

Follow-up of asymptomatic patients with SARS-CoV-2 infection

Temporal dynamics in viral shedding and transmissibility of COVID-19

Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management

CT imaging features of 4121 patients with COVID-19: a meta-analysis

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement

Random-effects (DerSimonian and Laird) method for meta-analysis. In Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Cochrane Collaboration

/chapter_9/9_4_3_1_random_effects_dersimonian_and_laird_ method_for.htm (accessed ?????)

R: a language and environment for statistical computing

R Foundation for Statistical Computing

The combination of estimates from different experiments

Measuring inconsistency in meta-analyses

How to conduct a meta-analysis of proportions in R: a comprehensive tutorial conducting meta-analyses of proportions in R

Bias in meta-analysis detected by a simple, graphical test

Asymptomatic patients with novel coronavirus disease (COVID-19)

The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing

Chest CT findings in cases from the cruise ship "Diamond Princess

patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in Shenzhen

Observation and analysis of 26 cases of asymptomatic SARS-COV2 infection

Recommendations on testing for funnel plot asymmetry

/chapter_10/10_4_3_1_recommendations_on_testing_for_funn el_plot_asymmetry.htm tle (accessed ??????)

Can people with asymptomatic or pre-symptomatic COVID-19 infect others: a systematic review of primary data? medRxiv

Comparison of transmissibility of coronavirus between symptomatic and asymptomatic patients: reanalysis of the Ningbo Covid-19 data. medRxiv

Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China

Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers

Incidentally discovered COVID-19 in low-suspicion patients-a threat to front line health care workers

American College of Radiology, and RSNA

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study